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RNA-seq Permits a Closer Look at
Normal Skin and Psoriasis Gene
Networks
David Quigley1,2,3
Psoriasis is a chronic inflammatory skin disease driven by aberrant signals from the
immune system. In this issue, Li et al. present the first large RNA-seq analysis of
gene expression in normal skin and psoriasis lesions, providing a more compre-
hensive view of mRNA expression than earlier microarray studies. This study’s size
enables gene co-expression analysis, a method illustrating which pathways are
altered by the presence of disease.
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The skin is a physical barrier, a thermo-
regulator, a radiation shield, and a
barrier against infection. When tissue-
resident and circulating immune cells
function properly, invading bacteria and
viruses are eliminated before they can
threaten the host. However, when these
powerful protective systems fail, the
resulting inflammatory and autoimmune
disorders can wreak havoc. Cutaneous
psoriasis vulgaris is one of the most
common immune-related inflammatory
disorders, affecting about 2% of Amer-
icans (Nestle et al., 2009). The most
visible symptoms of psoriasis are
scaly, puritic surface lesions formed by
an expansion of the outer cornified
layer and a thickened, hyperproli-
ferative epidermal layer that forms long
projections down into the dermis.
It is now generally agreed that these
changes are driven by activated T cells
that stimulate antigen-presenting cells
in the skin, resulting in hyperplasia
and a chronic pro-inflammatory micro-
environment (Lowes et al., 2007).
Understanding the pathogenesis of
psoriasis therefore requires consider-
ing the dynamic relationships bet-
ween innate and adaptive immunity
in skin.
A new technique for a familiar question
In vitro and mouse xenotransplantation
models have provided important
insights into the pathogenesis of psor-
iasis, but studying human tissue in situ
provides the most accurate picture of
disease development and progression.
Studies of increasing size and statistical
power have used microarray technol-
ogy to survey gene expression by
analysis of mRNA in psoriatic lesions,
uninvolved tissue from patients with
psoriasis, and skin from disease-
free individuals (Bowcock et al., 2001;
Zhou et al., 2003; Gudjonsson
et al., 2009). However, microarrays
are not sensitive enough to detect
rare transcripts, and it is difficult or
impossible to assess the relative
abundance of distinct gene isoforms or
mRNA transcripts for which an array
is not designed. There is evidence
that microRNAs and other noncoding
transcripts affect keratinocyte prolife-
ration and are also altered in psoriasis
(Xu et al., 2011). Thus, there is good
reason to believe that a more sensitive
and more general technique for
measuring mRNA expression would
improve our understanding of psoriasis
and other skin diseases.
In this issue, Li et al. (2014) present
the first large study to measure gene
expression in psoriasis using RNA-seq
on 92 psoriatic patients and 82 normal
individuals. RNA-seq provides greater
sensitivity than microarrays, especially
for transcripts expressed at very low
levels. It can identify the expression of
coding and noncoding transcripts that
are absent on microarray platforms.
Finally, it has the potential to quantify
alternatively spliced RNA isoforms.
Li et al. (2014) compare the RNA-seq
results to their earlier microarray
studies in psoriasis (Gudjonsson et al.,
2009), and they show that, although
differential expression analysis using
both methods gives similar results on
the most abundant transcripts, RNA-seq
identifies a large number of transcripts
expressed at low levels that could
not be confidently called differentially
expressed using a microarray study of
equivalent size.
Pathways, not just levels
Consistent with previous findings, Li
et al. (2014) identify significant
upregulation of genes known to be
associated with inflammatory respon-
ses, cell proliferation, and keratini-
zation in samples from patients with
psoriasis. There is strong evidence that
the pathogenesis of psoriasis involves
activation of inflammatory signaling by
activated TH17 T cells via the IL23
pathway (Di Cesare et al., 2009), and
Li et al. (2014) report substantial upregu-
lation of inflammatory signatures and
genes related to TH17 and IFN-gamma.
They use both differential expression
analysis and the Weighted Gene Co-
expression Network Analysis, a statisti-
cal approach that identifies modules of
significantly correlated genes (Figure 1a
and b). Genes within co-expression
modules are often related functionally
or expressed in the same cell type.
Network analysis permits the inference
that genes in a module, whose present
function is uncertain, may be related
functionally to better-studied genes
present in the same module. Gene
expression network analysis has been
applied fruitfully to numerous diseases,
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including obesity, skin cancer, and
Alzheimer’s disease (Emilsson et al.,
2008; Quigley et al., 2009; Zhang
et al., 2013).
‘‘...Analysis of a large
number of normal tissue




Li et al. (2014) identified motifs in
normal skin associated with physical
structures such as hair follicles, adipose
tissues, and erector pili muscles,
as well as with processes such as
keratinization. In psoriatic lesions, the
most interesting upregulated motifs
were related to myeloid cells and T
cells. The authors found significant
decreases in expression levels of IL37
and confirmed that the IL37 protein
is not present in psoriatic lesions
by immunostaining. IL37 was part
of a psoriatic co-expression module
enriched for genes expressed in the
stratum granulosum, an epithelial layer
that is diminished in psoriasis. It may be
that disruption in the cell population
expressing IL37 is responsible for its
reduced expression. However, IL37 is
an important anti-inflammatory IL-1
family cytokine (Nold et al., 2010),
and reduced IL37 levels are compati-
ble with the pro-inflammatory micro-
environment in psoriasis.
A question of proportion
A fundamental question in gene
expression analysis is the extent to
which changes in gene expression are
cell intrinsic, as opposed to changing
proportions of cell populations within
a tissue (Figure 1c). Histopatho-
logical examination of tissue sections
gives an indispensible grounding
in the proportions of cell populations.
Another approach is to sort cells by
FACS using markers specific for cell
types of interest, but this requires
live cells, well-validated markers, and
a willingness to discard information
from the cells that are excluded by
sorting. Given the importance of
cross-talk between T cells and keratino-
cytes in psoriasis, there is value in
measuring the expression from all cell
types that reside in skin. Li et al. (2014)
used gene expression measurements
taken from dermal and epidermal
tissues isolated by laser-capture micro-
scopy to identify genes that are expre-
ssed preferentially in each compartment
and are expressed at consistent levels
in normal and psoriasis tissues. They
identified a decrease in the relative
quantity of dermal-specific gene expres-
sion in psoriasis, consistent with the
known increase in the epidermal com-
partment compared with the dermis.
For logistical and ethical reasons, until
recently there has been a dearth of cohort
studies of normal human tissues other
than blood, and even fewer studies using
RNA-seq. Although many early micro-
array studies of disease were performed
with a small number of normal controls,
analysis of a large number of normal
tissue samples is crucial for understanding
how tissues change during the progres-
sion of psoriasis. The ongoing GTEx
project to analyze normal tissues in hun-
dreds of healthy individuals will increase
considerably the number of normal tissue
samples available for analysis (Lonsdale
et al., 2013). The value of control tissues
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Figure 1. Correlation analysis identifies changed relationships between genes. (a) Expression levels of two hypothetical genes (solid and open circles) measured in
normal and diseased tissue samples. Although each gene is expressed at the same level on average in both conditions, their expression levels are only correlated in
disease. This relationship would not be evident from analysis of gene expression levels. (b) Gene expression levels in normal and diseased tissue samples expressed
as heat maps, with higher expression brighter yellow and lower expression darker blue. Correlation analysis can identify sets of genes that are significantly
correlated with each other in only one state. These genes may be upregulated, downregulated, or not be significantly different in expression levels. A decrease
in gene expression between normal and diseased tissue can be complex to interpret when cell population proportions change. (c) In a schematic illustration,
expansion of cells in the epidermis (rectangles) compared with cells in the dermis (hexagons) without a change in expression levels is illustrated at the top.
A decrease in expression of dermal cells (colored blue, as in the heat map) without change in the relative cell population proportions is illustrated at the
bottom. In both cases, the microarray will report a decrease in dermal gene expression relative to epidermal gene expression; additional analysis is required
to understand to what extent each scenario applies.
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and by using either the patient’s own
unaffected tissue or samples appropriately
matched to the patient population for
important risk factors. Statistical approa-
ches such as gene co-expression analysis
require larger sample sizes than can be
accommodated by laser-capture micro-
scopy, so further development and appli-
cation of methods that cope with and
exploit diverse cell populations within
a sample will be quite useful. RNA-seq
is now the technology of choice for
genomic studies, although microarray
will continue to be attractive in large
studies in which RNA-seq analysis is not
economically feasible. Li et al. (2014)
have illustrated the use of these
approaches and the data they present
will inform studies of psoriasis and the
fields of skin biology and immunology.
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An Unexpected Role: UVA-Induced
Release of Nitric Oxide from Skin May
Have Unexpected Health Benefits
Gary M. Halliday1 and Scott N. Byrne1,2
UVR has deleterious and beneficial effects on human health. In this issue, Liu et al.
(2014) show that UVA decreases blood pressure and increases blood flow and
heart rate in humans, which is beneficial to the cardiovascular system. This is likely
mediated by UVA causing release of nitric oxide (NO) from skin stores. This
mediator may have additional effects on human health.
Journal of Investigative Dermatology (2014) 134, 1791–1794. doi:10.1038/jid.2014.33
UVA radiation has beneficial effects on
the cardiovascular system
UVR from the sun causes considerable
damage to the skin, including photoa-
ging, the formation of skin cancer, and
suppression of adaptive immunity. UV
causes production of reactive oxygen
species (ROS) in the skin, resulting in
oxidative stress. It damages DNA, sub-
sequently fixing mutations if the cell
does not die or if the damage is not
repaired before cell division. UV-indu-
ced ROS also damage proteins and
lipids, altering cellular signaling and
other essential cellular functions. How-
ever, UV also has some health benefits,
as reviewed recently (Juzeniene et al.,
2011). Seasonal and latitudinal variat-
ions in cardiovascular disease have led
to suggestions that sunlight may be of
benefit for these diseases (Juzeniene
et al., 2011), but the evidence for this
has been inconclusive. There could
be multiple explanations other than
sunlight exposure for this association,
including nutrition and a more active
lifestyle associated with warmer
temperatures. This is an active area of
research likely to yield new and
interesting associations between UV
effects on the skin and human health.
Although this relationship between
sunlight exposure and cardiovascular
disease has often been linked to
vitamin D (Juzeniene et al., 2011), a
different mediator, nitric oxide (NO) has
been implicated by a new study in this
issue of JID. Liu et al. (2014) report that
UVA (320–400 nm) lowers blood
pressure, increases blood flow in the
forearm, and increases heart rate in
healthy human volunteers. The mag-
nitude of these effects was sufficient to
be of cardiovascular benefit and possibly
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